𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyroxine augmentation of fluoxetine treatment for resistant depression in the elderly: An open trial

✍ Scribed by Yoram Barak; Daniel Stein; Joseph Levine; Aliza Ring; Jack Chadjez; Avner Elizur

Book ID
119175176
Publisher
Elsevier Science
Year
1996
Tongue
French
Weight
229 KB
Volume
11
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Thyroxine Augmentation of Fluoxetine Tre
Thyroxine Augmentation of Fluoxetine Treatment for Resistant Depression in the Elderly: An Open Trial
✍ YORAM BARAK; DANIEL STEIN; JOSEPH LEVINE; ALIZA RING; JACK HADJEZ; AVNER ELIZUR; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 415 KB πŸ‘ 2 views

Drug resistant depression is a confounding entity. More so in populations of elderly depressives where addition of lithium or antidepressant combinations are possibly hazardous. We present an open-trial of thyroxine in elderly patients diagnosed as suffering from resistant depression. Methods -Thyro

Olanzapine augmentation of milnacipran f
Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study
✍ Shuken Boku; Takeshi Inoue; Hiroshi Honma; Shigehiro Matsubara; Shin Nakagawa; T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Objective Olanzapine augmentation of fluoxetine, a selective serotonin reuptake inhibitor, is an effective augmentation therapy for treatment‐resistant depression (TRD). However, studies of olanzapine augmentation of other antidepressants are few. We investigated the efficacy and safety of olanz